Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets

Oct 30, 2009 - Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR® (fenofibrate) tablets, 48 mg and 145 mg.

The details can be read here.